Sage Journals: Discover world-class research

Retricted access

Research article

First published 2003-08

Is the Renal Dosimetry for [ 90 Y-DOTA 0,Tyr 3 ]Octreotide Accurate Enough to Predict Thresholds for Individual Patients?

Mark W. Konijnenberg

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1999-12

Receptor-mediated Radionuclide Therapy with 90 Y-DOTA-D-Phe 1 -Tyr 3 -Octreotide: Preliminary Report in Cancer Patients

G. Paganelli, S. Zoboli, M. Cremonesi [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2004-02

Effects of Intravenous Amino Acid Administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher™]) Treatment

David Bushnell, Yusuf Menda, Thomas O'Dorisio [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2000-12

Comparative Dosimetry of Copper-64 and Yttrium-90-Labeled Somatostatin Analogs in a Tumor-Bearing Rat Model

Jason S. Lewis, Richard Laforest, Michael R. Lewis [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2003-10

Tyr 3 -Octreotide and Tyr 3 -Octreotate Radiolabeled with 177 Lu or 90 Y: Peptide Receptor Radionuclide Therapy Results In Vitro

Astrid Capello, Eric P. Krenning, Wout A.P. Breeman [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2003-08

Assessment of Hepatic Toxicity from Treatment with 90 Y-SMT 487 (OctreoTher™) in Patients with Diffuse Somatostatin Receptor Positive Liver Metastases

David Bushnell, Yusuf Menda, Mark Madsen [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2004-02

Receptor Radionuclide Therapy with 90 Y-DOTATOC in Patients with Medullary Thyroid Carcinomas

Lisa Bodei, Daria Handkiewicz-Junak, Chiara Grana [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2005-02

A Comparison of High- Versus Low-Linear Energy Transfer Somatostatin Receptor Targeted Radionuclide Therapy In Vitro

Tapan Nayak, Jeffrey Norenberg, Tamara Anderson [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results